Jeil Pharma Holdings Inc reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 18,211.71 million compared to KRW 1,782.11 million a year ago. Net income was KRW 9,811.1 million compared to net loss of KRW 2,219.38 million a year ago.

Basic earnings per share from continuing operations was KRW 639 compared to basic loss per share from continuing operations of KRW 145 a year ago. Basic earnings per share was KRW 639 compared to basic loss per share of KRW 145 a year ago.